Organic food during a famine?
Two thirds of Canadians bought organic groceries on a weekly basis in 2020, but with the rising cost of food, families are having to make tough decisions at the cash register.
Canada must have a deadline for returning to budgetary balance
Finance Minister and Deputy Prime Minister Chrystia Freeland said this week that she didn’t want to set a deadline for the return to a balanced budget.
Canada needs to export more energy, to more places
Earlier last week, Russia cut off natural gas supplies to Bulgaria and Poland in retribution for sanctions related to the ongoing war with Ukraine.
The Mirage of American Economic Nationalism
Economic nationalism unfortunately seems to be in vogue south of the border, and the latest Buy American provisions may have serious repercussions for Canadian manufacturers.
Budgetary Balance: A Fantasy for the Federal Government
The federal government loosens the purse strings with such ease that there is good reason to worry about the national debt—already gargantuan—of over $1.262 trillion.
More Oil… Fewer Pipelines?
President Biden has acknowledged the need for more oil, and is looking for ways to get it from Canada, but without resurrecting the Keystone XL pipeline, which he killed his first day in office.
Web Giants: Let’s Not Create a New Bureaucratic Branch
We learned on March 29 that the federal government is preparing to table a piece of legislation to force Web giants to sign agreements that would require them to pay out sums of money to the media whose news stories they relay.
Canadian Hospitals Aren’t the Best in the World?
We Canadians like to think we lead the world when it comes to health care. The facts, however, tell a different story.
Charter Schools Are Public Schools
Charter schools in Alberta are autonomous and non-profit, and they follow the curriculum set out by the province. Yet critics are complaining about the diversion of funding from public schools—even though charter schools are public schools.
Let’s talk, briefly, about pharmaceutical innovation
Leading up to the 2022 federal budget, one of the hopes of the pharmaceutical sector is that the government will repeal and rethink certain regulatory updates to the Patented Medicine Prices Review Board.